Comparative Outcomes of Doxorubicin and Cyclophosphamide with Sequential versus Concurrent Paclitaxel in the Adjuvant Treatment of Non-Metastatic Breast Cancer: A Cross-Sectional Analytical Study

Comparative Outcomes of Doxorubicin and Cyclophosphamide with Sequential versus Concurrent Paclitaxel in the Adjuvant Treatment of Non-Metastatic Breast Cancer: A Cross-Sectional Analytical Study

Introduction: Studies have compared the efficacy and toxicities of doxorubicin and cyclophosphamide every three weeks for four cycles followed by four cycles of paclitaxel every three weeks (AC/T); with paclitaxel, doxorubicin, and cyclophosphamide (TAC) every three weeks for six cycles for adjuvan...

Full description

Saved in:
Bibliographic Details
Main Authors: Bishal Paudel, Bishnudutta Paudel, Rakshya Shrestha, Bishal Panthi, Ramila Shilpakar, Soniya Dulal, Sanjeev Kharel, Reechashree Dhunagana, Yogendra Prasad Singh, Bipsana Shrestha
Format: Article
Language:English
Published: Nepal Medical Association 2025-06-01
Series:Journal of Nepal Medical Association
Subjects:
breast cancer
chemotherapy
cyclophosphamide
doxorubicin
paclitaxel
Online Access:https://www.jnma.com.np/jnma/index.php/jnma/article/view/9130
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.jnma.com.np/jnma/index.php/jnma/article/view/9130

Similar Items